- 1. B Prime Alpha Regulatory Subunit
- [Ubiquitously expressed as 3 isoforms by human PPP2R5C Gene (PP2A Subunit B Family), Protein Phosphatase 2 Regulatory Subunit B Gamma is a regulatory subunit of PP2A. Nuclear Gamma-3 is serine phosphorylated, while nuclear Gamma-1 is not. A major Ser/Thr phosphatase implicated in negative control of cell growth and division, PP2A core enzyme consists of a 36-kDa catalytic C subunit and a constant 65-kDa regulatory/structural A subunit that interact with either a B regulatory subunit or with cell signaling molecules, that likely modulate substrate selectivity, catalytic activity, and subcellular localization, yielding the trimeric holoenzyme. Different subunit isoforms can generate many forms of PP2A, which may differ in substrate specificity, subcellular localization, or tissue specific expression. (NCI) ( NCI )] (UMLS (NCI) C1335546) B56G;
PP2A B Subunit B Prime Gamma;
PP2A B Subunit B56 Gamma;
PP2A B Subunit PR61 Gamma;
PP2A B Subunit R5 Gamma;
PPP2R5C;
Protein Phosphatase 2 Regulatory Subunit B Gamma;
Protein Phosphatase 2A Regulatory Subunit B56 Gamma;
Serine/Threonine Protein Phosphatase 2A 56 kDa Regulatory Subunit Gamma =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 8. BPD
- [chronic lung disease of infants, possibly related to oxygen toxicity or barotrauma, characterized by bronchiolar metaplasia and interstitial fibrosis. ( CSP )] (UMLS (CSP) C0006287) =Disease or Syndrome ;
=Infant, Premature, Diseases;
Lung Diseases |
- 2. B Prolymphocytic Leukemia
- [A malignant B-cell lymphoproliferative process affecting the blood, bone marrow, and spleen. The B-prolymphocytes are medium-sized, round lymphoid cells with prominent nucleoli. The B-prolymphocytes must exceed 55% of lymphoid cells in the blood. Cases of transformed chronic lymphocytic leukemia (CLL) and CLL with increased prolymphocytes are excluded. The prognosis is poor. (WHO, 2001) ( NCI )] (UMLS (NCI) C0475801) =Neoplastic Process
| - 9. BPH NOS W UR OBS/LUTS
- [ ] (UMLS (ICD9CM) C1260426) Hyperplasia of prostate, unspecified, with urinary obstruction and other lower urinary symptoms (LUTS) =Disease or Syndrome
|
- 3. B-Protein
- [shares 40% amino acid homology with sequence of mouse tyrosinase; has no tyrosinase activity; converts 5,6-dihydroxyindole-2-carboxylic acid to melanochrome in premelanosomes ( NCI )] (UMLS (NCI) C1455498) Catalase B;
Glycoprotein 75;
TRP-1;
Tyrosinase Related Protein-1;
Tyrosinase-Related Protein 1;
TYRP;
TYRP1;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 10. BPH NOS W/O UR OBS/LUTS
- [ ] (UMLS (ICD9CM) C1719540) Hyperplasia of prostate, unspecified, without urinary obstruction and other lower urinary symptoms (LUTS) =Disease or Syndrome
|
- 4. B2036-PEG
- [ ] (UMLS (CSP) C0768710) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 11. BPH W URINARY OBS/LUTS
- [ ] (UMLS (ICD9CM) C1260419) Hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (LUTS) =Disease or Syndrome
|
- 5. B43-PAP
- [An immunotoxin comprised of a ribosome inhibitory plant toxin, Pokeweed Antiviral Protein (PAP), conjugated with a murine IgG1 anti-CD19 monoclonal antibody selectively targeting B-lineage progenitor cells, causing apoptosis. ( NCI )] (UMLS (NCI) C0796424) B43-PAP Immunotoxin;
B43-Pokeweed Antiviral Protein Immunotoxin;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 12. BPH W/O URINARY OBS/LUTS
- [ ] (UMLS (ICD9CM) C1719538) Hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptoms (LUTS);
=Disease or Syndrome |
- 6. BP
- [A group of islands in the South Pacific Ocean, east of Papua New Guinea. (NCI) ( NCI )] (UMLS (NCI) C0037623) =Geographic Area ;
| - 13. BPS _ Blood product dispense status
- (UMLS (HL7) C1549265) =Health Care Activity =Event Type;
|
- 7. BP Observation Status Codes Interpretation
- (UMLS (HL7) C1547886) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Post original as wrong, e.g., transmitted for wrong patient;
Record coming over is a correction and thus replaces a final status;
Deletes the BPX record;
"Final status; Can only be changed with a corrected status"
;Order detail description only (no status);
Preliminary status;
| |
home
